PMCJ-9 (BCG Connaught strain) phase III clinical study

Trial Profile

PMCJ-9 (BCG Connaught strain) phase III clinical study

Phase of Trial: Phase III

Latest Information Update: 31 May 2018

At a glance

  • Drugs BCG (Primary)
  • Indications Bladder cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Nippon Kayaku
  • Most Recent Events

    • 08 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top